ORTEXORTEX News
Tracking ROL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
RO
Trader NoteROL

Rollins Shorts Hit Year High as Options Flip Defensive

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 4 min readdata as of 21 Oct 2026, 19:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ROL has accumulated the largest short position in at least a year, built almost entirely over the past six weeks, with the stock gaining 3.7% this week despite the bearish positioning.

Short interest reached 5.95% of the free float on October 20, equivalent to 28.6 million shares. The build has been dramatic: positions stood at just 11.9 million shares in early September. That is a near-tripling in under seven weeks, achieved cheaply. Cost to borrow is 0.44%, down 18% on the week. Availability is 1,492%, meaning roughly 15 shares remain available to borrow for every one already lent out. The Rollins family's 13D filing, representing a 33.3% stake held by the R. Randall Rollins Voting Trust as last disclosed on September 21, keeps the effective free float tight, but the lending market shows no sign of stress. There is no squeeze dynamic here; shorts built this position at leisure.

What changed sharply on Tuesday was options sentiment. The put/call ratio jumped to 1.005, more than four standard deviations above its 20-day average of 0.45, and close to the 52-week peak of 1.26. For context, the ratio had been running between 0.39 and 0.42 for most of the past month. That abrupt flip toward downside protection landed on earnings day itself, with results due after the close on October 21. The jump contrasts with the more relaxed options picture described in the prior notes from this week, where the PCR was near its mean and well below any threshold of concern. The shift is meaningful: traders who had been relatively calm about the outcome bought protection aggressively in the final session.

The Street has spent the past week cutting targets with little dissent on direction. Every firm to act in the past ten days moved their number lower, nobody raised. Canaccord and Bernstein trimmed to $36 and $35 respectively on October 19. Citigroup went to $32 on October 15, below where the stock traded at the time. JP Morgan cut to $35 and Morgan Stanley to $43, the latter still the most constructive name on the list with an Overweight rating. The consensus sits at Hold, with a mean target of $39.82, implying 19% above the current price. The bear case, as laid out by Benzinga, centres on three consecutive quarters of organic revenue missing the 7% to 8% target, with Q2 coming in at 5.7% organic growth, full-year guidance cut to 6%, and incremental margins slashed from a 25% to 30% range to 10%. Agentic AI search results, which the bears argue are routing leads toward smaller local operators rather than Orkin, are the structural concern that is hardest to dismiss. Morgan Stanley's bull case rests on the commercial channel, where 7.2% organic growth in Q2 held up better, and on Rollins' recurring-revenue model with retention above 80%.

The most recent comparable earnings print was in July, when the stock fell 10% to 11% on the day and extended those losses over the following week. That was itself the second consecutive quarter of significant post-earnings selling. The pattern has established a clear market expectation: a Q3 miss or another guidance reduction carries a well-defined downside template. This quarter's print is the first opportunity to break that pattern, or to reinforce it.

ORTEX forecasts an 87% probability that ROL qualifies for a share count increase in the CRSP US Small index at the December 2026 Quarterly Review, which would require approximately $164 million of passive buying. In the same review, ORTEX puts the probability of deletion from the CRSP US Large and CRSP US Mid indexes at 91% and 90% respectively, which would generate roughly $130 million of combined passive selling. The key price for those deletions is $43.92, the level at which the market cap rule flips. The stock is 31.7% below that line. Rank date is December 4, with announcement on December 7 and the trade executing on December 22. The net passive flow picture is therefore modestly negative, weighted toward selling.

US environmental services peers moved broadly higher this week. RSG gained 5.9%, WM rose 9.4%, and WCN added 10.3%, all outpacing ROL's 3.7% weekly gain. The underperformance is consistent with a stock carrying company-specific growth questions that its waste-management peers do not share. Wikipedia attention for ROL was running at a z-score of 2.36 against its own 90-day history as of late September, a reflection of the heightened focus heading into the print rather than any operational signal.

The data leaves the picture in an unusual place: a large, cheaply built short position, a defensive options flip on the final session before earnings, a wall of analyst target reductions, an equity value recovering modestly on the week, and a passive rebalance calendar that points to net selling pressure into December regardless of what the Q3 numbers show.

Stocks in this article

See the live data behind this article on ORTEX.

Open ROL on ORTEX →

How this article was generated

Generated
21 Oct 2026, 19:03
Data as of
21 Oct 2026, 19:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex RebalancePrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.